None listed
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1) Patients with non-acute low back pain (onset of symptoms was more than 3 weeks ago) and an average pain intensity of Numeric Rating Scale (NRS) = 4 over the last week. 2) Patients confirmed to have a malposition diagnosed according to Chuna manual therapy through plain radiographic imaging (X-ray). 3) Individuals who have voluntarily agreed to participate in the clinical trial and have signed the informed consent form.
Exclusion criteria
Exclusion criteria: 1) Patients diagnosed with serious specific pathologies that could be the cause of the low back pain (e.g., metastatic spinal tumor, acute fracture, spinal dislocation, moderate to severe scoliosis). 2) Patients with structural abnormalities of the lumbar spine (e.g., sacralization, lumbarization), a history of osteoporosis, or suspected fracture. 3) Patients within 3 months of lumbar spine surgery. 4) Patients with other chronic diseases that could interfere with the interpretation of treatment effects or results (e.g., chronic renal failure). 5) Patients with progressive neurological deficits or serious accompanying neurological symptoms, such as cauda equina syndrome. 6) Patients with internal fixation or stabilization devices (surgical implants) in the lumbar spine from a previous surgery. 7) Patients with contraindications for ICT (Interferential Current Therapy), such as pain from malignancy or use of a cardiac pacemaker. 8) Patients currently taking steroids, immunosuppressants, psychoactive medications, or other drugs that may affect the study results. 9) Patients who have received Chuna therapy, strong narcotic analgesics, anesthetics, or invasive treatments (e.g., acupuncture, injections) within the last week. 10) Patients who have received a nerve block procedure in the lumbar region within the last 2 months. 11) Patients who are pregnant, breastfeeding, or planning to become pregnant. 12) Patients who plan to receive any surgery, procedure, or medication that could affect the assessment of the study results during the treatment period (4 weeks), without direction from the study investigator. 13) Any other patients deemed unsuitable for participation in the clinical trial by the principal investigator.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| NRS(Numerical rating scale) for Low back pain | — |
Secondary
| Measure | Time frame |
|---|---|
| NRS for leg pain ;Oswestry disability index (ODI);European Quality of Life 5 Dimension (EQ-5D);Korean version of the Roland-Morris Disability Questionnaire;Thoraco lumbar spine range of motion (ROM);Chuna Manual Therapy-based X-ray Assessment;Exploratory Efficacy Assessment (Analysis of the rate of additional procedures or surgery, treatment discontinuation rate, and rescue medication usage);Responder and Non-responder Analysis;Safety Assessment (Adverse Events) | — |
Countries
Korea, Republic of
Contacts
Catholic Kwandong University International St.Mary's Hospital